Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India
PURPOSE: Biomarker—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) —discordance plays an essential role in the management and prognosis of patients with metastatic breast cancer. Rates of discordance have been previously reported around 12%...
Main Authors: | Ajay Gogia, S. V. Suryanarayana Deo, Dayanand Sharma, Rakesh K. Phulia, Sanjay Thulkar, Prabhat S. Malik, Sandeep Mathur |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2019-04-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.18.00184 |
Similar Items
-
Clinicopathologic Characteristics and Treatment Outcomes of Patients With Up-Front Metastatic Breast Cancer: Single-Center Experience in India
by: Ajay Gogia, et al.
Published: (2019-03-01) -
Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases
by: Suryanarayana Deo, et al.
Published: (2021-06-01) -
Malignant peripheral nerve sheath tumors (MPNST) – Clinicopathological study and treatment outcome of twenty-four cases
by: DattaGupta Sidharth, et al.
Published: (2006-08-01) -
Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
by: Yu Guo, et al.
Published: (2020-10-01) -
Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute
by: Raja Pramanik, et al.
Published: (2019-05-01)